<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>OAR@UM Community:</title>
  <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/12351" />
  <subtitle />
  <id>https://www.um.edu.mt/library/oar/handle/123456789/12351</id>
  <updated>2026-04-27T12:00:25Z</updated>
  <dc:date>2026-04-27T12:00:25Z</dc:date>
  <entry>
    <title>A further case of dandy-walker malformation, cystic dysplastic kidneys and congenital hepatic fibrosis : possibly a new syndrome</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/105871" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/105871</id>
    <updated>2023-02-01T10:12:48Z</updated>
    <published>1995-01-01T00:00:00Z</published>
    <summary type="text">Title: A further case of dandy-walker malformation, cystic dysplastic kidneys and congenital hepatic fibrosis : possibly a new syndrome
Abstract: This paper presents a further report of a child with Dandy-Walker malformation, cystic dysplastic kidneys and congenital hepatic fibrosis.</summary>
    <dc:date>1995-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>The effect of pamidronate on bone density and bone resorption in patients with multiple myeloma</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/105870" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/105870</id>
    <updated>2023-02-01T10:00:47Z</updated>
    <published>1995-01-01T00:00:00Z</published>
    <summary type="text">Title: The effect of pamidronate on bone density and bone resorption in patients with multiple myeloma
Abstract: The object of this study was to monitor the effect of the bisphosphonate, pamidronate, on bone density and bone resorption, as determined by collagen markers, in patients with multiple myeloma. The urinary excretion of the collagen crosslinks, pyridinoline and deoxypyridinoline, expressed as a ratio to urinary creatinine, has been determined using an ELISA method. Bone density was measured at 3 monthly intervals. Paraprotein levels, LFTs, calcium, CBC, U and Es, creatinine and collagen crosslinks were measured monthly. Patients who responded to treatment and remained clinically well showed an improvement in bone density and a fall in collagen crosslinks excretion, suggesting a reduced morbidity.</summary>
    <dc:date>1995-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Fibreoptic bronchoscopy - indications, results and pick-up rates of various sampling modalities</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/105869" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/105869</id>
    <updated>2023-02-01T09:54:19Z</updated>
    <published>1995-01-01T00:00:00Z</published>
    <summary type="text">Title: Fibreoptic bronchoscopy - indications, results and pick-up rates of various sampling modalities
Abstract: An adult of the 328 fibreoptic bronchoscopies carried out by one respiratory physician [SM] at SLH in last &#xD;
27mths [40.1 % of all bronchoscopies in SLH in study period] was carried out in order to study the local picture of the indications, results and pick-up rates of various sampling modalities used during this useful procedure. Of these 328 bronchoscopies, 251 were carried on males [12-90 yrs] and 77 on females [age 19-89yrs] of these bronchoscopies were carried out in the ITU settling, both as emergency therapeutic measures [common indications: lobar collapse, bronchial toilet for increased secretions] and as diagnostic procedures [better sampling for c/s]. All but two of the other bronchoscopies were carried out using Alfenta nyl as sedation and topical xylocaine as local airway anaesthesia. Unresolving pneumonias and CXR abnormalities were two of the commonest indications.</summary>
    <dc:date>1995-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Audit of a miscarriage clinic (1992-1995)</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/105868" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/105868</id>
    <updated>2024-12-06T06:02:02Z</updated>
    <published>1995-01-01T00:00:00Z</published>
    <summary type="text">Title: Audit of a miscarriage clinic (1992-1995)
Abstract: A Miscarriage Clinic was set-up in the department of Obstetrics and Gynaecology, in March, 1992 in order to provide a service for patients who have suffered at least two miscarriages. The service provides the chance for counselling and support for these patients together with a thorough investigation into the possible causes of the abortion. The investigations start with a detailed abortion history, blood tests: CBC, U&amp;E&amp;C, LFT, 75gms QGTT, APTT, a TFT and a day 2 and a day 21 hormone profile, torch screen and an&#xD;
auto-antibody profile. Anatomical anomalies are screened by salpingography and ultrasound. A karyotype on&#xD;
both patients is also carried out. By November 1995, 108 patients had been referred to the clinic the age range being 19 to 44 years. Of these 17 are currently still undergoing investigations and 12 have been lost to follow-up.</summary>
    <dc:date>1995-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

